#222 AFib Stroke Prevention: WATCHMAN, DOACs, and the CHAMPION-AF Trial | Beyond Journal Club Segment with NEJM Group

If your patient asks you about a left atrial appendage closure device, what should you tell them?
In the latest episode of the Beyond Journal Club podcast from CORE IM and NEJM Group, the hosts will help you:
Understand the trade-offs: stroke prevention, bleeding, procedural risks, and medications afterward.
Build clinical judgment: weigh which approach may better serve the individual patient, beyond the trial’s headline.
Learn from thoughtful counseling: hear how you might discuss the evidence, acknowledge uncertainty, and explore what matters to your patients.
🔹Sponsor: ACP MKSAP Oakstone CME
Use the code "CORE25" for 25% off: https://www.coreimpodcast.com/MKSAP7​
🔹Transcript and Show Notes
01:09 | What the Watchman is, and why it should work?
05:58 | The checkered history: PROTECT-AF and PREVAIL
09:06 | The plot continues: PRAGUE-17, OPTION, OCEAN, and CLOSURE-AF
12:35 | CHAMPION-AF: the biggest test yet
15:03 | Reading the fine print
19:23 | A local solution to a systemic problem
22:45 | How patients hear about it
25:44 | So what do we tell our patients?
29:52 | Takeaways
Tags: IMCore, Internal Medicine, Medical Education, WATCHMAN device, Atrial Fibrillation, Cardiology, DOAC Anticoagulation, Primary Care, Hospital Medicine
Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840
Our Sponsors:
* Check out ElevenReader and use my code PODCAST for a great deal: https://elevenreader.io
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy